H

HUTCHMED (China) Ltd
HKEX:13

Watchlist Manager
HUTCHMED (China) Ltd
HKEX:13
Watchlist
Price: 28 HKD 1.45% Market Closed
Market Cap: 24.4B HKD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+32%
Revenue
Forecast
+17%
Operating Income
Forecast
N/A
Net Income
Forecast
-2%

Wall Street
Price Targets

Price Targets Summary
HUTCHMED (China) Ltd

Wall Street analysts forecast HUTCHMED (China) Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HUTCHMED (China) Ltd is 36.89 HKD with a low forecast of 23.13 HKD and a high forecast of 49.46 HKD.

Lowest Forecast
Wall Street Target
23.13 HKD
17% Downside
Average Forecast
Wall Street Target
36.89 HKD
32% Upside
Highest Forecast
Wall Street Target
49.46 HKD
77% Upside
Lowest
Price Target
23.13 HKD
17% Downside
Average
Price Target
36.89 HKD
32% Upside
Highest
Price Target
49.46 HKD
77% Upside
HUTCHMED (China) Ltd Competitors:
Price Targets
HITI
High Tide Inc
127% Upside
A
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
13% Upside
HIKAL
Hikal Ltd
54% Upside
K
GUD
Knight Therapeutics Inc
25% Upside
HITI
High Tide Inc
127% Upside
A
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
13% Upside
HIKAL
Hikal Ltd
54% Upside
K
GUD
Knight Therapeutics Inc
25% Upside
AARTIDRUGS
Aarti Drugs Ltd
13% Downside
N
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
44% Upside

Revenue
Forecast

Revenue Estimate
HUTCHMED (China) Ltd

For the last 8 years the compound annual growth rate for HUTCHMED (China) Ltd's revenue is 14%. The projected CAGR for the next 3 years is 17%.

14%
Past Growth
17%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
HUTCHMED (China) Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
HUTCHMED (China) Ltd

For the last 8 years the compound annual growth rate for HUTCHMED (China) Ltd's net income is 16%. The projected CAGR for the next 3 years is -2%.

16%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HUTCHMED (China) Ltd's stock price target?
Price Target
36.89 HKD

According to Wall Street analysts, the average 1-year price target for HUTCHMED (China) Ltd is 36.89 HKD with a low forecast of 23.13 HKD and a high forecast of 49.46 HKD.

What is HUTCHMED (China) Ltd's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for HUTCHMED (China) Ltd's revenue is 14%. The projected CAGR for the next 3 years is 17%.

What is HUTCHMED (China) Ltd's Net Income forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for HUTCHMED (China) Ltd's net income is 16%. The projected CAGR for the next 3 years is -2%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 270,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.